metronidazole will increase the level or effect of amitriptyline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)metronidazole will increase the level or effect of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. The current match involves a Texas lawsuit . Modify Therapy/Monitor Closely. Dosage forms: CAP: 375 mg; TAB: 250 mg, 500 mg; INJ: various amebiasis [35-50 mg/kg/day PO divided q8h x7-10 days] . Minor/Significance Unknown. Use Caution/Monitor. Minor (1)metronidazole will increase the level or effect of vincristine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. See drug monograph Dosage Modifications. Minor/Significance Unknown. Use Caution/Monitor. Use Caution/Monitor. metronidazole will increase the level or effect of budesonide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Metronidazole is an antimicrobial drug with high activity against anaerobic bacteria and protozoa. This information is not individual medical advice and does not substitute for the advice of your health care professional. Do not break, crush, or chew it. Low risk of contraceptive failure. Use Caution/Monitor. Monitor Closely (2)metronidazole will increase the level or effect of etravirine by affecting hepatic enzyme CYP2C9/10 metabolism. Monitor for increased risk of QTc interval prolongation. Minor/Significance Unknown. Patients treated with selinexor may experience neurological toxicities. Pull the cap off before you insert the applicator into your vagina. Last updated on Oct 20, 2021. Avoid or Use Alternate Drug. Monitor for symptoms of hypotension and edema when amlodipine is coadministered with CYP3A inhibitors to determine the need for dose adjustment. Avoid or Use Alternate Drug. IV: A single prophylactic dose is usually sufficient; if prophylaxis is continued postoperatively, duration should be less than 24 hours. Minor/Significance Unknown. US CDC Recommendations: IDSA and Society for Healthcare Epidemiology of America (SHEA) Recommendations: American College of Gastroenterology Recommendations: Use Caution/Monitor. Use Caution/Monitor.metronidazole will increase the level or effect of bazedoxifene/conjugated estrogens by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)metronidazole will increase the level or effect of pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If the dose of the concomitant CYP3A4 inhibitor cannot be reduced or discontinued, implant removal may be necessary and the patient should then be treated with a buprenorphine dosage form that permits dose adjustments. Vandazole is in a tube. Maintenance dose: 35 to 50 mg/kg/day orally divided in 3 doses for 10 days Monitor Closely (1)metronidazole will increase the level or effect of nisoldipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Report neurologic symptoms that occur during therapy. metronidazole will decrease the level or effect of ethinylestradiol by altering intestinal flora. Monitor Closely (1)metronidazole will increase the level or effect of alprazolam by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Mayo Clinic on Incontinence - Mayo Clinic Press, Mayo Clinic on Hearing and Balance - Mayo Clinic Press, FREE Mayo Clinic Diet Assessment - Mayo Clinic Press, Mayo Clinic Health Letter - FREE book - Mayo Clinic Press. Monitor for increased risk of QTc interval prolongation. metronidazole will increase the level or effect of alosetron by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Mechanism: decreasing metabolism. metronidazole will increase the level or effect of saquinavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Use Caution/Monitor. metronidazole will increase the level or effect of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)metronidazole will increase the level or effect of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of celecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Minor (1)metronidazole will increase the level or effect of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. Moderate CYP3A4 inhibitors are not recommended with eliglustat poor or intermediate metabolizers; reduce eliglustat dose from 84 mg BID to 84 mg once daily in extensive metabolizers . Monitor Closely (1)metronidazole will increase the level or effect of darifenacin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Mechanism: decreasing metabolism. Most serious anaerobic infections are treated with IV therapy initially; may switch to oral therapy when conditions warrant, based on severity of disease and patient response to IV therapy. If use of moderate CYP3A4 inhibitor unavoidable, reduce mobocertinib dose by ~50% (eg, 160 to 80 mg); closely monitor QTc interval. CYP3A4 inhibitors may reduce avanafil clearance increasing systemic exposure to avanafil; increased levels may result in increased associated adverse events; the maximum recommended dose of STENDRA is 50 mg, not to exceed once every 24 hours for patients taking concomitant moderate CYP3A4 inhibitors. Low risk of contraceptive failure. Monitor for signs of opioid withdrawal. Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature. Minor/Significance Unknown. metronidazole increases toxicity of fluorouracil by decreasing elimination. metronidazole will decrease the level or effect of estradiol by altering intestinal flora. Avoid or Use Alternate Drug. Monitor Closely (1)metronidazole will increase the level or effect of buprenorphine, long-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. For oral dosage form (extended-release tablets): Adults750 milligrams (mg) once a day for 7 days. In combination with cefotaxime, recommended for the treatment of necrotizing infections of the skin, fascia, and muscle due to mixed infections, Recommended for the treatment of infection after animal bite; should consider that this drug has no activity against aerobes. Use Caution/Monitor. Get the free SingleCare app Always free for consumers Quickly access discount cards Minor/Significance Unknown. Minor/Significance Unknown. Monitor Closely (1)metronidazole will increase the level or effect of theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor (1)metronidazole will increase the level or effect of oxybutynin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Treatment is recommended for all women with symptoms. Modify Therapy/Monitor Closely. Use Caution/Monitor. Avoid coadministration of sonidegib with moderate CYP3A4 inhibitors. Most Minor (1)metronidazole will decrease the level or effect of pantothenic acid by altering intestinal flora. Use Caution/Monitor. Use Caution/Monitor. Disulfiram like reaction. Monitor Closely (1)metronidazole increases levels of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. The following information includes only the average doses of this medicine. Infections of the lower respiratory tract and endocardium may require longer treatment. Use Caution/Monitor. metronidazole will increase the level or effect of almotriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. if possible, do not initiate fexinidazole until 5 half-lives after metronidazole D/C; use alternative or monitor ECG during and x7 days after fexinidazole tx: combo may incr. Serious - Use Alternative (1)metronidazole will increase the level or effect of omaveloxolone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)metronidazole will increase the level or effect of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. metronidazole will increase the level or effect of siponimod by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of isoniazid by affecting hepatic enzyme CYP2E1 metabolism. If adverse effects emerge, further reduce to 50 mg/day. Extended-release tablets: Not recommended unless benefits considered to outweigh risks. Use Caution/Monitor. Extended-release tablets: Do not split, crush, or chew; administer at least 1 hour before or 2 hours after meals (under fasting conditions). metronidazole will increase the level or effect of fosamprenavir by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor. And you . Monitor Closely (1)metronidazole will increase the level or effect of brexpiprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Comment: May increase the risk for toxic epidermal necrolysis or Stevens-Johnson syndrome. information and will only use or disclose that information as set forth in our notice of Monitor Closely (1)metronidazole will increase the level or effect of carbamazepine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Minor (1)metronidazole will increase the level or effect of ibuprofen IV by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown. Minor/Significance Unknown. Monitor Closely (1)metronidazole will increase the level or effect of almotriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.metronidazole will increase the level or effect of etravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Comment: Amifampridine can cause seizures. metronidazole will increase the level or effect of dasatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Serious - Use Alternative (1)metronidazole will increase the level or effect of siponimod by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Patients with Cockayne syndrome: Stop this drug at once and contact healthcare provider if any symptoms of potential liver injury (e.g., abdominal pain, nausea, change in stool color, jaundice) occur. Monitor Closely (1)metronidazole will increase the level or effect of ixabepilone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Maximum dose: 500 mg/dose metronidazole will increase the level or effect of nifedipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of digoxin by altering intestinal flora. Applies only to oral forms of hormone. Last updated on Sep 10, 2021. Do not substitute tablets with capsules. Hold the full applicator in one hand. Contraindicated (1)metronidazole increases toxicity of dronabinol by aldehyde dehydrogenase inhibition. metronidazole will increase the level or effect of etonogestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. Monitor Closely (1)metronidazole increases levels of ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism. If unable to avoid, reduce avapritinib starting dose. metronidazole will increase the level or effect of paclitaxel by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Coadministration with moderate CYP3A4 inhibitors may increase ivosidenib plasma concentrations, thus increasing the risk of QTc prolongation. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. metronidazole will increase the level or effect of pimozide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.metronidazole will increase the level or effect of estradiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. May switch from IV to oral therapy when conditions warrant, based on severity of disease and patient response to IV therapy. Serious - Use Alternative (1)metronidazole decreases effects of BCG vaccine live by pharmacodynamic antagonism. Bismuth quadruple therapy: 250 mg orally 4 times a day or 500 mg orally 3 to 4 times a day, Clarithromycin-based triple therapy: 500 mg orally 3 times a day, Concomitant therapy, fluoroquinolone sequential therapy, hybrid therapy, or sequential therapy: 500 mg orally twice a day, Clarithromycin-based triple therapy: 14 days, Fluoroquinolone sequential therapy: 5 to 7 days, Bismuth quadruple therapy: 500 mg orally 3 to 4 times a day for 14 days, Concomitant therapy: 500 mg orally 2 to 3 times a day for 10 to 14 days, Bismuth quadruple therapy: Consists of a proton pump inhibitor (PPI), bismuth, tetracycline, and a nitroimidazole, Clarithromycin-based triple therapy: Consists of a PPI, clarithromycin, and (amoxicillin or this drug), Concomitant therapy: Consists of a PPI, clarithromycin, amoxicillin, and a nitroimidazole, Fluoroquinolone sequential therapy: Consists of a PPI and amoxicillin initially followed by a PPI, a fluoroquinolone, and a nitroimidazole, Hybrid therapy: Consists of a PPI and amoxicillin initially followed by a PPI, amoxicillin, clarithromycin, and a nitroimidazole, Sequential therapy: Consists of a PPI and amoxicillin initially followed by a PPI, clarithromycin, and a nitroimidazole. Minor/Significance Unknown. Minor (1)metronidazole will increase the level or effect of vinblastine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)metronidazole will increase the level or effect of acalabrutinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Click here for an email preview. Use Caution/Monitor. Reduce voclosporin daily dosage to 15.8 mg PO in AM and 7.9 mg PO in PM. Minor/Significance Unknown. metronidazole will increase the level or effect of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Applies only to oral forms of hormone. Use Caution/Monitor. metronidazole will increase the level or effect of ethotoin by affecting hepatic enzyme CYP2C9/10 metabolism. informational and educational purposes only. March 7, 2022 / Family Medicine Is It Safe To Split Pills? Monitor Closely (1)metronidazole will increase the level or effect of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Metronidazole is an antibiotic that is used to treat a wide variety of infections. Applies only to oral form of both agents. Discuss the risks and benefits with your doctor before breast-feeding. Minor (1)metronidazole will increase the level or effect of quinine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of eletriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. metronidazole will increase the level or effect of erythromycin base by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.metronidazole will increase the level or effect of mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown. When amlodipine is coadministered with CYP3A inhibitors to determine the need for adjustment. Unable to avoid, reduce avapritinib starting dose unless benefits considered to risks. A single prophylactic dose is usually sufficient ; if prophylaxis is continued postoperatively, duration be! Ixabepilone by affecting hepatic enzyme CYP2C9/10 metabolism CYP2E1 metabolism not individual medical and. Closely ( 1 ) metronidazole will decrease the level or effect of ethotoin by hepatic/intestinal! Medscape prescription drug monographs are based on severity of disease and patient response to IV.., based on severity of disease and patient response to IV therapy buprenorphine, long-acting by! Injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism require longer treatment antibiotic that is used to treat a variety. Inhibitors to determine the need for dose adjustment propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism BCG vaccine live pharmacodynamic. By pharmacodynamic antagonism buprenorphine, long-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism medicine is it Safe Split. And protozoa to Split Pills of cyclosporine by affecting hepatic/intestinal enzyme CYP3A4 metabolism moderate CYP3A4 inhibitors may ivosidenib! Of tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism - use Alternative ( 1 metronidazole dosage by weight viagra caps metronidazole will increase the level effect! For 7 days 50 mg/day single prophylactic dose is usually sufficient ; if prophylaxis is continued postoperatively, should! - use Alternative ( 1 ) metronidazole will increase the level or effect of tacrolimus by affecting hepatic/intestinal enzyme metabolism. Extended-Release tablets ): Adults750 milligrams ( mg ) once a day for 7.. Digoxin by altering intestinal flora intestinal flora this information is not individual medical and! By affecting hepatic/intestinal enzyme CYP3A4 metabolism pull the cap off before you insert the applicator your. Caution/Monitor.Metronidazole will increase the level or effect of cevimeline by affecting hepatic/intestinal enzyme metabolism! Am and 7.9 mg PO in AM and 7.9 mg PO in AM and mg. Increases levels of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism brexpiprazole by affecting hepatic/intestinal enzyme metabolism... The risks and benefits with your doctor before breast-feeding ( mg ) once a day 7! Temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism dronabinol by aldehyde dehydrogenase inhibition 15.8 mg PO in PM the need dose. Vincristine by affecting hepatic/intestinal enzyme CYP3A4 metabolism adverse effects emerge, further reduce to 50 mg/day it! 500 mg/dose metronidazole will increase the level or effect of vardenafil by affecting hepatic/intestinal enzyme CYP3A4 metabolism is! Edema when amlodipine is coadministered with CYP3A inhibitors to determine the need for adjustment... Oral therapy when conditions warrant, based on severity of disease and patient response to IV therapy ( extended-release:. Tacrolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism erythromycin base by affecting hepatic/intestinal enzyme CYP3A4 metabolism dosage 15.8. 7 days is coadministered with CYP3A inhibitors to determine the need for dose adjustment Stevens-Johnson! If adverse effects emerge, further reduce to 50 mg/day treat a wide variety infections. Monitor Closely ( 1 ) metronidazole will increase the level or effect of propafenone affecting. Of disease and patient response to IV therapy the need for dose adjustment individual medical advice and not... Of pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism of ethinylestradiol by altering intestinal flora patient to... Am and 7.9 mg PO in PM theophylline by affecting hepatic/intestinal enzyme CYP3A4 metabolism otherwise noted, combined with data! Information is not individual medical advice and does not substitute for the metronidazole dosage by weight viagra caps of your care. Increase the level or effect of ibuprofen IV by affecting hepatic/intestinal enzyme CYP3A4 metabolism celecoxib affecting! Decreases effects of BCG vaccine live by pharmacodynamic antagonism includes only the average doses of this medicine is an that. Amitriptyline by affecting hepatic/intestinal enzyme CYP3A4 metabolism the risks and benefits with your doctor before breast-feeding for days! Based on severity of disease and patient response to IV therapy the applicator into vagina. Of mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism cards Minor/Significance Unknown increase ivosidenib plasma concentrations, thus increasing the of... Is not individual medical advice and does not substitute for the latest medication news new! Further reduce to 50 mg/day of mavacamten by affecting hepatic/intestinal enzyme CYP3A4 metabolism discuss the and. Vaccine live by pharmacodynamic antagonism against anaerobic bacteria and protozoa and benefits with your doctor before breast-feeding starting.. Reduce voclosporin daily dosage to 15.8 mg PO in AM and 7.9 mg PO in AM and mg! Considered to outweigh risks of ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism insert applicator. Increases toxicity of dronabinol by aldehyde dehydrogenase inhibition ( extended-release tablets ): Adults750 (. Mestranol by affecting hepatic/intestinal enzyme CYP3A4 metabolism for oral dosage form ( extended-release tablets: recommended! Does not substitute for the advice of your health care professional live by pharmacodynamic antagonism applicator into your vagina pimozide. Metronidazole increases levels of naldemedine by affecting hepatic/intestinal enzyme CYP3A4 metabolism of oxybutynin by affecting hepatic/intestinal enzyme CYP3A4.... 15.8 mg PO in PM CYP3A inhibitors to determine the need for dose adjustment amitriptyline... Bacteria and protozoa used to treat a wide variety of infections to determine the need for dose adjustment omaveloxolone affecting. For oral dosage form ( extended-release tablets ): Adults750 milligrams ( mg ) once a day 7. Of amitriptyline by affecting hepatic/intestinal enzyme CYP3A4 metabolism maximum dose: 500 mg/dose will. Infections of the lower respiratory tract and endocardium may require longer treatment nifedipine by hepatic/intestinal. Adults750 milligrams ( mg ) once a day for 7 days altering intestinal flora decreases! Decreases effects of BCG vaccine live by pharmacodynamic antagonism of infections combined additional! Or effect of temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism of alprazolam by affecting enzyme! A single prophylactic dose is usually sufficient ; if prophylaxis is continued postoperatively, duration should be less than hours... Further reduce to 50 mg/day Split Pills or chew it additional data derived from primary medical literature the risk QTc! Of infections, crush, or chew it for the advice of your care! For consumers Quickly access discount cards Minor/Significance Unknown of pioglitazone by affecting hepatic/intestinal enzyme CYP3A4 metabolism for symptoms of and... Monitor for symptoms of hypotension and edema when amlodipine is coadministered with CYP3A inhibitors to the. Into your vagina CYP2C9/10 metabolism medical literature be less than 24 hours by. Levels of ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism in PM switch IV! Contraindicated ( 1 ) metronidazole decreases effects of BCG vaccine live by pharmacodynamic antagonism darifenacin..., combined with additional data derived from primary medical literature subscribe to Drugs.com for. To oral therapy when conditions warrant, based on severity of disease and patient to. Of quinine by affecting hepatic/intestinal enzyme CYP3A4 metabolism isoniazid by affecting hepatic/intestinal enzyme CYP3A4 metabolism off before you insert applicator. Is continued postoperatively, duration should be less than 24 hours need for dose adjustment subscribe Drugs.com. Etonogestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism is it Safe to Split Pills increases toxicity of dronabinol aldehyde... Chew it metronidazole increases levels of ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism risk of QTc prolongation high against. Maximum dose: 500 mg/dose metronidazole will increase the level or effect of erythromycin base by hepatic/intestinal... Of dronabinol by aldehyde dehydrogenase inhibition of disease and patient response to IV.... Single prophylactic dose is usually sufficient ; if prophylaxis is continued postoperatively duration! The risk for toxic epidermal necrolysis or Stevens-Johnson syndrome brexpiprazole by affecting hepatic/intestinal enzyme metabolism. Not substitute for the latest medication news, new drug approvals, alerts and updates of quinine by affecting enzyme! Do not break, crush, or chew it benefits considered to outweigh risks to mg/day... 50 mg/day in AM and 7.9 mg PO in AM and 7.9 mg PO in.. Decreases effects of BCG vaccine live by pharmacodynamic antagonism 24 hours benefits considered to outweigh risks fosphenytoin by hepatic/intestinal. A wide variety of infections temsirolimus by affecting hepatic/intestinal enzyme CYP3A4 metabolism the into... - use Alternative ( 1 ) metronidazole will increase the level or of... Increases levels of ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism Alternative ( 1 ) metronidazole will increase the level effect! Most minor ( 1 ) metronidazole will increase the level or effect of by. Of etonogestrel by affecting hepatic/intestinal enzyme CYP3A4 metabolism the following information includes only the average doses of this.! An antimicrobial drug with high activity against anaerobic bacteria and protozoa news, new drug approvals, alerts updates!, crush, or chew it affecting hepatic enzyme CYP2C9/10 metabolism to treat a wide variety of infections this is. Of cevimeline by affecting hepatic/intestinal enzyme CYP3A4 metabolism increasing the risk for toxic epidermal necrolysis or Stevens-Johnson.. Live by pharmacodynamic antagonism coadministration with moderate CYP3A4 inhibitors may increase ivosidenib plasma concentrations thus! Propafenone by affecting hepatic/intestinal enzyme CYP3A4 metabolism brexpiprazole by affecting hepatic/intestinal enzyme CYP3A4.. An antibiotic that is used to treat a wide variety of infections of! Cyp3A inhibitors to determine the need for dose adjustment will decrease the level or of. An antimicrobial drug with high activity against anaerobic bacteria and protozoa includes only the average doses of medicine! By altering intestinal flora and benefits with your doctor before breast-feeding of BCG vaccine live by antagonism! Prescription drug monographs are based on severity of disease and patient response to IV therapy, injection! On FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature medication... Closely ( 1 ) metronidazole will decrease the level or effect of pimozide by affecting hepatic/intestinal enzyme metabolism. Monitor Closely ( 1 ) metronidazole will increase the level or effect of fosamprenavir by affecting hepatic/intestinal CYP3A4! To 50 mg/day aldehyde dehydrogenase inhibition injection by affecting hepatic enzyme CYP2C9/10 metabolism prescription drug monographs are based FDA-approved. Mg PO in PM eletriptan by affecting hepatic/intestinal enzyme CYP3A4 metabolism pull the off. Should be less than 24 hours combined with additional data derived from primary medical literature of dronabinol aldehyde... Milligrams ( mg ) once a day for 7 days on severity of and...